News

The U.S. Centers for Disease Control and Prevention has merged H5N1 bird flu updates with routine updates for seasonal ...
The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.
MRNA's mRNA-1010 flu vaccine outperforms GSK's shot by 26.6% in a large phase III trial of adults 50 and older.
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.
The CDC concludes its emergency response for H5N1 bird flu due to decreased animal infections and no new human cases since ...
If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...
According to the CDC, there has been a decline in animal infections and no reports of human cases since February.
The U.S. Centers for Disease Control and Prevention has ended its emergency response to the H5N1 bird flu outbreak, a move ...
Short sellers started to panic in recent days. Moderna (MRNA), which has a short interest of 16.44%, might benefit from two ...
The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety of mRNA technology, despite an extensive history of testing.
The U.S. Centers for Disease Control and Prevention ended its emergency response for bird flu as the outbreak that sickened ...